Last reviewed · How we verify

NCT05105256: IAPRP

Platelet-rich Plasma Infiltration Versus Corticosteroid Infiltration (Prednisolone) in Treatment of Lumbar Facet Joint Syndrome

Completed NA Last updated 11 July 2024
What this trial tests

NA trial testing Prednisolone in Low Back Pain in 76 participants. Completed in 16 May 2024.

Timeline
21 December 2021
Primary endpoint
16 May 2024
16 May 2024

Quick facts

Lead sponsorCHU de Reims
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment76
Start date21 December 2021
Primary completion16 May 2024
Estimated completion16 May 2024
Sites1 location across France

Drugs / interventions tested

Conditions studied

Sponsor

CHU de Reims — full company profile →

Who can join

18 and older, any sex, with Low Back Pain or Osteoarthritis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The prevalence of low back pain is estimated at 90% . Recent studies have shown that 15% to 52% of back pain is attributable to facet joint syndrome . Being the only vertebral joints provided with a synovial membrane, the posterior inter-apophyseal joints are subject, like all other peripheral joints, to degenerative arthritis phenomena. These phenomena most often result in the release of pro-inflammatory cytokines resulting in cartilage degradation. PRP or platelet rich plasma is an autologous blood product obtained after centrifugation of a peripheral blood sample. The PRP has many anti-inflammatory properties. Numerous studies have shown the interest of intra-articular infiltration of PRP in osteoarthritis of the knee but also in tendinopathies of the shoulder and a few studies also suggest the use of PRP in the spine "intra-disc, epidural and posterior joints) . Corticosteroid infiltrations in the posterior lumbar joints constituting the standard treatment in posterior inter-apophyseal osteoarthritis. The goal is to obtain a new therapeutic weapon in the management of this frequent and invalid disease for patients who are often elderly and with other comorbidity.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Prednisolone

Trials testing the same drug.

Other recruiting trials for Low Back Pain

Currently open trials in the same condition.

Other CHU de Reims trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05105256.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing